# A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis

> **NCT05061693** · PHASE2 · COMPLETED · sponsor: **Incyte Corporation** · enrollment: 146 (actual)

## Conditions studied

- Prurigo Nodularis

## Interventions

- **DRUG:** INCB054707
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05061693
- **Lead sponsor:** Incyte Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-04
- **Primary completion:** 2023-08-11
- **Final completion:** 2024-02-28
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05061693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05061693, "A Study to Evaluate the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05061693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*